Stock Market News

4 days Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. Investor's Business Daily

Novo Nordisk stock crashed Friday after the firm’s next-generation weight-loss drug missed expectations in a highly anticipated study.
The post Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. appeared first on …

Amgen (AMGN)

4 hours Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

13 hours Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

3 days Amgen stock gains on Novo Nordisk’s weightloss drug blunder FXStreet

6 days Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

1 week Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen Investor's Business Daily

2 weeks Why Amgen (AMGN) is a Top Growth Stock for the Long-Term Zacks

2 weeks Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

2 weeks Here’s Why Amgen (AMGN) is a Strong Value Stock Zacks

2 weeks Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks

2 weeks The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

2 weeks Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha

3 weeks The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem Zacks

3 weeks Top Stock Reports for Amgen, Eaton & Enzo Biochem Zacks

3 weeks Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha

3 weeks Amgen Stock Falls 12% in a Month: Should You Buy the Dip? Zacks

3 weeks Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger The Wall Street Journal

4 weeks Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks

4 weeks Is Amgen Stock Still a Buy After an Unexpected Reveal of Data? Yahoo Finance

4 weeks AMGN Stock Down Despite Strong Data From Obesity Drug Study Zacks

4 weeks Amgen’s Phase 2 Results Were Not Bad, Don’t Let Mr. Market Fool You Seeking Alpha

4 weeks Amgen: Checks All The Wrong Boxes Seeking Alpha

4 weeks Final Trade: JWN, IWM, GCO, AMGN YouTube

4 weeks Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher Raymond YouTube

4 weeks Amgen stock sinks as weightloss drug fails to impress FXStreet

4 weeks Amgen: MariTide Underwhelms, But There Are Ways To Win Seeking Alpha

4 weeks Chart of the Day: Amgen YouTube

4 weeks Cramer’s Stop Trading: Amgen YouTube

4 weeks Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know. Yahoo Finance

4 weeks Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily

4 weeks Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know. Yahoo Finance

4 weeks Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau YouTube

4 weeks These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and More Yahoo Finance

1 month Why Amgen (AMGN) is a Top Value Stock for the Long-Term Zacks

1 month Amgen Sells Off: Keep Calm And Buy The Dip Seeking Alpha

1 month Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

1 month Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcare FXStreet

1 month Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate Zacks

1 month Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript) Seeking Alpha

1 month Trade Tracker: Joe Terranova sells Amgen and buys XBI YouTube

1 month Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily

1 month Amgen dismisses bone density concerns related to its new weight-loss drug Investing.com

1 month Amgen sinks as Cantor flags issues with obesity drug YouTube

1 month Amgen stock falls as analysts mull over weight loss drug’s bone density data CNBC

1 month Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity Shot Investor's Business Daily

2 months Big Pharma’s Obesity Bonanza Faces New Tests The Wall Street Journal

2 months Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market Seeking Alpha

2 months Analyst Report: AMGEN Inc. Yahoo Finance

2 months Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHC Yahoo Finance

2 months Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript Seeking Alpha

2 months Amgen Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.